151 related articles for article (PubMed ID: 36567903)
1. USP2 Inhibits Lung Cancer Pathogenesis by Reducing ARID2 Protein Degradation via Ubiquitination.
Zhu L; Chen Z; Guo T; Chen W; Zhao L; Guo L; Pan X
Biomed Res Int; 2022; 2022():1525216. PubMed ID: 36567903
[TBL] [Abstract][Full Text] [Related]
2. Cullin 2-RBX1 E3 ligase and USP2 regulate antithrombin ubiquitination and stability.
Xu D; Wu J; Chen J; Jiang L; Chen J; Bao W; Chen X; Yang Q; Zhang X; Yao L; Su H; Liu J
FASEB J; 2021 Aug; 35(8):e21800. PubMed ID: 34324733
[TBL] [Abstract][Full Text] [Related]
3. The deubiquitylase USP2 maintains ErbB2 abundance via counteracting endocytic degradation and represents a therapeutic target in ErbB2-positive breast cancer.
Zhang J; Liu S; Li Q; Shi Y; Wu Y; Liu F; Wang S; Zaky MY; Yousuf W; Sun Q; Guo D; Wang T; Zhang Y; Wang Y; Li M; Liu H
Cell Death Differ; 2020 Sep; 27(9):2710-2725. PubMed ID: 32327714
[TBL] [Abstract][Full Text] [Related]
4. USP2 is an SKP2 deubiquitylase that stabilizes both SKP2 and its substrates.
Zhang F; Zhao Y; Sun Y
J Biol Chem; 2021 Oct; 297(4):101109. PubMed ID: 34425107
[TBL] [Abstract][Full Text] [Related]
5. Small Molecule Inhibition of the Ubiquitin-specific Protease USP2 Accelerates cyclin D1 Degradation and Leads to Cell Cycle Arrest in Colorectal Cancer and Mantle Cell Lymphoma Models.
Davis MI; Pragani R; Fox JT; Shen M; Parmar K; Gaudiano EF; Liu L; Tanega C; McGee L; Hall MD; McKnight C; Shinn P; Nelson H; Chattopadhyay D; D'Andrea AD; Auld DS; DeLucas LJ; Li Z; Boxer MB; Simeonov A
J Biol Chem; 2016 Nov; 291(47):24628-24640. PubMed ID: 27681596
[TBL] [Abstract][Full Text] [Related]
6. MiR-155-5p promotes oral cancer progression by targeting chromatin remodeling gene ARID2.
Wu M; Duan Q; Liu X; Zhang P; Fu Y; Zhang Z; Liu L; Cheng J; Jiang H
Biomed Pharmacother; 2020 Feb; 122():109696. PubMed ID: 31918270
[TBL] [Abstract][Full Text] [Related]
7. Loss of deubiquitylase USP2 triggers development of glioblastoma via TGF-β signaling.
Tu Y; Xu L; Xu J; Bao Z; Tian W; Ye Y; Sun G; Miao Z; Chao H; You Y; Liu N; Ji J
Oncogene; 2022 Apr; 41(18):2597-2608. PubMed ID: 35332268
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of USP2 Enhances TRAIL-Mediated Cancer Cell Death through Downregulation of Survivin.
Lee TG; Woo SM; Seo SU; Kim S; Park JW; Chang YC; Kwon TK
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628997
[TBL] [Abstract][Full Text] [Related]
9. Ribonucleotide reductase holoenzyme inhibitor COH29 interacts with deubiquitinase ubiquitin-specific protease 2 and downregulates its substrate protein cyclin D1.
Zhu M; Wang H; Ding Y; Yang Y; Xu Z; Shi L; Zhang N
FASEB J; 2022 May; 36(5):e22329. PubMed ID: 35476303
[TBL] [Abstract][Full Text] [Related]
10. Validation of catalytic site residues of Ubiquitin Specific Protease 2 (USP2) by molecular dynamic simulation and novel kinetics assay for rational drug design.
Ullah S; Junaid M; Liu Y; Chen S; Zhao Y; Wadood A
Mol Divers; 2023 Jun; 27(3):1323-1332. PubMed ID: 35932436
[TBL] [Abstract][Full Text] [Related]
11. DTL promotes cancer progression by PDCD4 ubiquitin-dependent degradation.
Cui H; Wang Q; Lei Z; Feng M; Zhao Z; Wang Y; Wei G
J Exp Clin Cancer Res; 2019 Aug; 38(1):350. PubMed ID: 31409387
[TBL] [Abstract][Full Text] [Related]
12. The Deubiquitylase USP2 Regulates the LDLR Pathway by Counteracting the E3-Ubiquitin Ligase IDOL.
Nelson JK; Sorrentino V; Avagliano Trezza R; Heride C; Urbe S; Distel B; Zelcer N
Circ Res; 2016 Feb; 118(3):410-9. PubMed ID: 26666640
[TBL] [Abstract][Full Text] [Related]
13. Targeting the deubiquitinase
Zhang S; Guo Y; Zhang S; Wang Z; Zhang Y; Zuo S
Oncol Rep; 2023 Oct; 50(4):. PubMed ID: 37594087
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of USP2 eliminates cancer stem cells and enhances TNBC responsiveness to chemotherapy.
He J; Lee HJ; Saha S; Ruan D; Guo H; Chan CH
Cell Death Dis; 2019 Mar; 10(4):285. PubMed ID: 30918246
[TBL] [Abstract][Full Text] [Related]
15. Identifying USPs regulating immune signals in Drosophila: USP2 deubiquitinates Imd and promotes its degradation by interacting with the proteasome.
Engel E; Viargues P; Mortier M; Taillebourg E; Couté Y; Thevenon D; Fauvarque MO
Cell Commun Signal; 2014 Jul; 12():41. PubMed ID: 25027767
[TBL] [Abstract][Full Text] [Related]
16. LncRNA DRAIC inhibits proliferation and metastasis of gastric cancer cells through interfering with NFRKB deubiquitination mediated by UCHL5.
Zhang Z; Hu X; Kuang J; Liao J; Yuan Q
Cell Mol Biol Lett; 2020; 25():29. PubMed ID: 32351584
[TBL] [Abstract][Full Text] [Related]
17. USP2 promotes cell migration and invasion in triple negative breast cancer cell lines.
Qu Q; Mao Y; Xiao G; Fei X; Wang J; Zhang Y; Liu J; Cheng G; Chen X; Wang J; Shen K
Tumour Biol; 2015 Jul; 36(7):5415-23. PubMed ID: 25687182
[TBL] [Abstract][Full Text] [Related]
18. Deubiquitylating enzyme USP2 counteracts Nedd4-2-mediated downregulation of KCNQ1 potassium channels.
Krzystanek K; Rasmussen HB; Grunnet M; Staub O; Olesen SP; Abriel H; Jespersen T
Heart Rhythm; 2012 Mar; 9(3):440-8. PubMed ID: 22024150
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of ubiquitin-specific protease 2 possesses prognostic and diagnostic value and promotes the clear cell renal cell carcinoma progression.
Meng X; Xiong Z; Xiao W; Yuan C; Wang C; Huang Y; Tong J; Shi J; Chen Z; Liu C; Xie K; Xiong H; Chen K; Yang H; Zhang X
Ann Transl Med; 2020 Mar; 8(6):319. PubMed ID: 32355763
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of Ubiquitin-Specific Protease 2 (USP2) in the Heart Suppressed Pressure Overload-Induced Cardiac Remodeling.
Xing J; Li P; Hong J; Wang M; Liu Y; Gao Y; Dong J; Gu H; Li L
Mediators Inflamm; 2020; 2020():4121750. PubMed ID: 32963492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
